Blog
Guest CEO blog from Sandrine Miller-Montgomery:
Precision or Personalized Medicine – Is it Tomato or Tomahto?
At Micronoma we are putting everything we have into ensuring that development of diagnostics like our Oncobiota™ platform will be a key propellent for creating new opportunities in precision medicine by identifying cancer at its earliest stages. But first, a quick...
Team Spotlight: Asia Celestial Sison, Clinical
Laboratory Scientist
Asia started working for Micronoma in October 2022. She was born in the San Francisco Bay area but grew up in San Diego and has lived here for the last 25 years. As a Clinical Laboratory Scientist in Micronoma’s new clinical diagnostic lab, her main responsibility is...
Team Spotlight: Mauka Manuwai, Research Associate II
Mauka Manuwai joined the Micronoma team in July 2022 as a Research Associate II. Originally from Medford, Oregon, he decided to trade the evergreen trees for the salty waves and sandy beaches of San Diego in 2021. In Hawaiian, his name Mauka means: Towards the...
New Research Puts Fungi in Cancer Diagnosis Spotlight
Our recent collaboration with the Weizmann Institute of Science and the University of California San Diego found that fungi are ubiquitous in human cancer types and often interact with bacteria in synergistic, rather than competitive ways. This is the latest chapter...
Team Spotlight: Todd Czerwinski, Vice President of Business Development
Todd Czerwinski joined the Micronoma team formally in May of 2022 as the Vice President of Business Development. Originally from the suburbs of Detroit, he has been in San Diego since the summer of 1995 (he wants us to know it was early September '95 - officially...
Micronoma Keeps Science in the Driver’s Seat through Testing Economic Times
At Micronoma, we turn to science first to guide us down the road to delivering the first diagnostic platform technology using the microbiome to detect early-stage cancer. At the same time, we keep a watchful eye on our resources so we can steer clear of the...
Team Spotlight: Celia Sepulveda, Corporate Communications Director
Celia Sepulveda joined Micronoma formally in April of 2022 as the Corporate Communications Director, though she has been working with Micronoma as a consultant from the announced launch in fall of 2020. Born in Santa Rosa, California and raised in New Jersey, she has...
Team Spotlight: Andrew Lin CLS (Clinical Laboratory Scientist) Supervisor
Andrew Lin joined Micronoma in July 2021 as a CLS Supervisor and is responsible for building, operating, and managing a clinical lab that is compliant with all CLIA/CAP/NY regulations. Though originally from Yorba Linda, Ca, he has lived in San Diego for the last four...
The Economic Case for Early Screening
As we pave the way for better patient outcomes with the first minimally invasive microbiome-driven liquid biopsy technology, we also want to make sure that the important economic benefits that health insurance companies will reap from covering early cancer screening...
Team Spotlight: Stephen Wandro, Senior Scientist, Computational Biology
Stephen Wandro joined Micronoma in August 2020 as a senior scientist, with a speciality in analyzing DNA sequencing data. He is responsible for building computational pipelines and interpreting biological data with statistics and machine learning. He organizes and...
Micronoma Puts Machine Learning to Work
It’s no exaggeration to say the development of Micronoma’s Oncobiota™ microbiome-driven liquid-biopsy technology to detect cancer at an early stage would not be possible without extensive expertise and use of machine learning (ML) tools. Micronoma’s proprietary...
Team Spotlight: Chuck Tripp, Quality Manager
Chuck Rosales joined Micronoma in July 2021 as the quality manager, responsible for implementing and maintaining all compliance and quality procedures to ensure that patient testing is performed with the highest standards. Though born in Kansas, he has lived in San...
Why is Clonal Evolution Still a Sterile Theory?
Despite major revelations in the science of cancer, a classic theory of how it develops—clonal evolution—has remained a perplexing vestige of ‘sterile’ cancer biology. Arguing against the sterility of tumors, the last decade of research has revealed metabolically...
Hallmarks of Cancer Update Sharpens Focus on Micronoma’s Work
Inclusion of microbiome supports Micronoma’s efforts to improve cancer detection The “hallmarks of cancer” have captured the core features of cancer biology and served as a guide for future research since their original publication in Cell in 2000. Since then, the...
Team Spotlight: Gabriella Fanelli
Gabriella Fanelli, Executive Assistant Gabriella joined Micronoma in the Spring of 2021. Gabriella makes everything at Micronoma run smoothly and efficiently. As the only person on the team who’s not science-focused - she was an English literature major in college -...
Team Spotlight: Akanksha Singh-Taylor
Akanksha Singh-Taylor, Senior Scientist Akanksha Singh-Taylor joined Micronoma in September 2021 as a senior scientist on our wet lab side. Originally from Delhi, India, Akanksha moved to Houston when she was 10. During her work with children and adults with severe...
Cleaning Up Contamination Misconceptions
While researchers have typically seen microbes only as contaminants and discarded them, Micronoma has set itself apart by seeing the treasure trove of opportunity microbes represent to detect and identify cancer early. Using liquid biopsy--a simple blood...
Team Spotlight: Darryl Garrison
Darryl Garrison, Chief Operating Officer Meet Darryl, our Chief Operating Officer. Darryl has more than 20 years of experience in the molecular diagnostic industry. He has been involved in setting up and running molecular clinical laboratories and has been responsible...
Team Spotlight: Serena Fraraccio
Serena Fraraccio, Senior Scientist Serena Fraraccio’s road to becoming Micronoma’s first wet lab senior scientist started in her hometown in Isernia, Italy, where an interest in the environment and biology blossomed into a career that has gone from winters in Alaska...
Advances Push Cancer Research from Human-Centric to Microbiome-Focused
The recent realization that the microbiome impacts human health and disease states, as well as the rapid evolution of research tools has led to an exciting and critical juncture, when we can now go deeper than ever in understanding and using microbiome science for...
Team Spotlight: Eddie Adams
Eddie Adams, Chief Scientific Officer Eddie Adams has stacked up an impressive list of accomplishments and wealth of experience on his way to becoming Micronoma’s chief scientific officer (CSO), a role that enables him to combine his passion for solving problems with...
The Team Behind the Science
Micronoma’s founders each contribute unique skill sets and know-how to the company’s cutting-edge cancer detection platform. For any team to be successful, each member must bring something unique to the table. At the same time, the individual pieces and parts must...
The Case for Tackling One Cancer at a Time
While having generated a lot of buzz recently, early screening for multiple types of cancer at once may not be that ideal in practice- the path to clinical adoption could be taking on one cancer type at a time. In a perfect world, a simple blood test would catch all...
The Complexities of Early Lung Cancer Detection
Many obstacles stand in the way of current lung cancer detection methods, making it one of the deadliest cancers.
The Cancer Microbiome Relationship
One of the most promising developments in cancer research originates with the microbiome If there is one area of cancer research that is causing a lot of excitement, it’s the link between the disease and the microbiome, and with good reason: it presents an opportunity...
Website Terms of Use, Privacy Policy, and Licenses
Micronoma, INC., CLIA #05D2253538
Oncobiota™ LDT is under development and is currently not available for commercial use in any jurisdiction. Once available under CLIA license, Oncobiota™ will be available in the United States by prescription only.
Contact Us
If you have questions or would like to learn more, please email us at info@micronoma.com or learn about joining our team at Careers.
Micronoma
6342 Ferris Square
San Diego, CA 92121